Q2
AVR — Q2 2026 Financial Report Analysis
Anteris's Q2 net loss widened 40% to $29.1M as R&D rose 43% to fund manufacturing scale-up and the PARADIGM trial's US launch, while $260.9M of cash from January's raise covers roughly two and a half years at current burn.